These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15332712)

  • 1. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial.
    Berman SJ; Fogarty CM; Fabian T; Melnick D; Lesky W;
    J Chemother; 2004 Aug; 16(4):362-71. PubMed ID: 15332712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
    Alvarez Lerma F;
    J Chemother; 2001 Feb; 13(1):70-81. PubMed ID: 11233804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
    Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
    Alvarez Lerma F;
    Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
    Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
    Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.
    Finch RG; Pemberton K; Gildon KM
    J Chemother; 1998 Feb; 10(1):35-46. PubMed ID: 9531074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of nosocomial pneumonia: an experience with meropenem.
    Santos SS; Machado FR; Kiffer CR; Barone AA
    Braz J Infect Dis; 2001 Jun; 5(3):124-9. PubMed ID: 11506775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S; Punyo J
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1337-9. PubMed ID: 15793108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial.
    Hassan NA; Awdallah FF; Abbassi MM; Sabry NA
    Crit Care Med; 2018 Jan; 46(1):45-52. PubMed ID: 28857848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effect of continuous infusion of meropenem on bacterial pneumonia in the elderly].
    Okimoto N; Kibayashi T; Mimura K; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N; Ohba H
    Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):431-5. PubMed ID: 16841713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
    Kim A; Kuti JL; Nicolau DP
    Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
    Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
    Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
    Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M
    J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia.
    Ranzani OT; Ferrer M; Esperatti M; Giunta V; Bassi GL; Carvalho CR; Torres A
    Crit Care Med; 2012 Sep; 40(9):2552-61. PubMed ID: 22732293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.